Table 1.
No. (%) | |
---|---|
Total | 66 |
Sex | |
Male | 31 (48%) |
Female | 35 (52%) |
Age, median (years) | 58 |
KPS | |
90 – 100 | 39 (59%) |
70 – 80 | 26 (39%) |
≤ 60 | 1 (1%) |
Oligometastatic* | |
Yes | 36 (55%) |
No | 30 (45%) |
Intrathoracic only disease* | |
Yes | 33 (50%) |
No | 33 (50%) |
Prior systemic therapy* | |
Yes | 61 (92%) |
No | 5 (8%) |
Courses of SBRT, median (range) | |
Histology** | |
Leiomyosarcoma | 19 (29%) |
Undifferentiated pleomorphic sarcoma | 10 (15%) |
Liposarcoma | 7 (11%) |
Osteosarcoma | 7 (11%) |
Synovial | 5 (8%) |
Other | 18 (27%) |
At time of first course of lung SBRT
Other disease histologies include: Ewing (n = 4), chondrosarcoma (n = 3), myxofibrosarcoma (n = 2), glomangiosarcoma (n = 2), epithelioid (n = 2), peripheral nerve sheath (n = 2), alveolar (n = 1), undifferentiated with epithelioid and myxoid features (n = 1), perivascular epithelioid cell Tumor (n = 1)